189 related articles for article (PubMed ID: 25129990)
21. Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat.
Park SH; Farooq MA; Gaertner S; Bruckert C; Qureshi AW; Lee HH; Benrahla D; Pollet B; Stephan D; Ohlmann P; Lessinger JM; Mayoux E; Auger C; Morel O; Schini-Kerth VB
Cardiovasc Diabetol; 2020 Feb; 19(1):19. PubMed ID: 32070346
[TBL] [Abstract][Full Text] [Related]
22. Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat.
Zhou X; Ma L; Habibi J; Whaley-Connell A; Hayden MR; Tilmon RD; Brown AN; Kim JA; Demarco VG; Sowers JR
Hypertension; 2010 Apr; 55(4):880-8. PubMed ID: 20176997
[TBL] [Abstract][Full Text] [Related]
23. Glucocorticoids activate cardiac mineralocorticoid receptors in adrenalectomized Dahl salt-sensitive rats.
Ohtake M; Hattori T; Murase T; Takahashi K; Takatsu M; Ohtake M; Miyachi M; Watanabe S; Cheng XW; Murohara T; Nagata K
Nagoya J Med Sci; 2014 Feb; 76(1-2):59-72. PubMed ID: 25129992
[TBL] [Abstract][Full Text] [Related]
24. Cardiomyocyte-specific Bmal1 deletion in mice triggers diastolic dysfunction, extracellular matrix response, and impaired resolution of inflammation.
Ingle KA; Kain V; Goel M; Prabhu SD; Young ME; Halade GV
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1827-36. PubMed ID: 26432841
[TBL] [Abstract][Full Text] [Related]
25. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
[TBL] [Abstract][Full Text] [Related]
26. Effects of ramelteon on cardiac injury and adipose tissue pathology in rats with metabolic syndrome.
Uchinaka A; Kawashima Y; Sano Y; Ito S; Sano Y; Nagasawa K; Matsuura N; Yoneda M; Yamada Y; Murohara T; Nagata K
Ann N Y Acad Sci; 2018 Jun; 1421(1):73-87. PubMed ID: 29542814
[TBL] [Abstract][Full Text] [Related]
27. The Role of SGLT2 Inhibitor Ipragliflozin on Cardiac Hypertrophy and microRNA Expression Profiles in a Non-diabetic Rat Model of Cardiomyopathy.
Takasu T
Biol Pharm Bull; 2022; 45(9):1321-1331. PubMed ID: 36047201
[TBL] [Abstract][Full Text] [Related]
28. Anti-inflammatory effects of heat-killed Lactobacillus plantarum L-137 on cardiac and adipose tissue in rats with metabolic syndrome.
Uchinaka A; Azuma N; Mizumoto H; Nakano S; Minamiya M; Yoneda M; Aoyama K; Komatsu Y; Yamada Y; Murohara T; Nagata K
Sci Rep; 2018 May; 8(1):8156. PubMed ID: 29802339
[TBL] [Abstract][Full Text] [Related]
29. Deriving a cardiac ageing signature to reveal MMP-9-dependent inflammatory signalling in senescence.
Ma Y; Chiao YA; Clark R; Flynn ER; Yabluchanskiy A; Ghasemi O; Zouein F; Lindsey ML; Jin YF
Cardiovasc Res; 2015 Jun; 106(3):421-31. PubMed ID: 25883218
[TBL] [Abstract][Full Text] [Related]
30. Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction.
Brandt MM; Nguyen ITN; Krebber MM; van de Wouw J; Mokry M; Cramer MJ; Duncker DJ; Verhaar MC; Joles JA; Cheng C
J Cell Mol Med; 2019 Oct; 23(10):6666-6678. PubMed ID: 31368189
[TBL] [Abstract][Full Text] [Related]
31. Characterization of cardiac size and function in SHRSP.Z-Lepr(fa)/IzmDmcr rats, a new animal model of metabolic syndrome.
Tada Y; Kagota S; Matsumoto M; Naito Y; Shibata H; Nejime N; Tsujino T; Koshiba M; Masuyama T; Shinozuka K
Biol Pharm Bull; 2010; 33(12):1971-6. PubMed ID: 21139235
[TBL] [Abstract][Full Text] [Related]
32. Repetitive hyperthermia attenuates progression of left ventricular hypertrophy and increases telomerase activity in hypertensive rats.
Oyama J; Maeda T; Sasaki M; Higuchi Y; Node K; Makino N
Am J Physiol Heart Circ Physiol; 2012 May; 302(10):H2092-101. PubMed ID: 22427516
[TBL] [Abstract][Full Text] [Related]
33. Abnormal amounts of intracellular calcium regulatory proteins in SHRSP.Z-Lepr(fa)/IzmDmcr rats with metabolic syndrome and cardiac dysfunction.
Kagota S; Maruyama K; Tada Y; Wakuda H; Nakamura K; Kunitomo M; Shinozuka K
Can J Physiol Pharmacol; 2013 Feb; 91(2):124-33. PubMed ID: 23458196
[TBL] [Abstract][Full Text] [Related]
34. Myocardial myocyte remodeling and fibrosis in the cardiometabolic syndrome.
Hayden MR; Chowdhury N; Govindarajan G; Karuparthi PR; Habibi J; Sowers JR
J Cardiometab Syndr; 2006; 1(5):326-33. PubMed ID: 17679785
[TBL] [Abstract][Full Text] [Related]
35. High-phosphorus/zinc-free diet aggravates hypertension and cardiac dysfunction in a rat model of the metabolic syndrome.
Suzuki Y; Mitsushima S; Kato A; Yamaguchi T; Ichihara S
Cardiovasc Pathol; 2014; 23(1):43-9. PubMed ID: 23932324
[TBL] [Abstract][Full Text] [Related]
36. A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone.
López-Andrés N; Martin-Fernandez B; Rossignol P; Zannad F; Lahera V; Fortuno MA; Cachofeiro V; Díez J
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2372-82. PubMed ID: 21926338
[TBL] [Abstract][Full Text] [Related]
37. Folic acid attenuates remodeling and dysfunction in the aging heart through the ER stress pathway.
Ye S; Zhou X; Chen P; Lin JF
Life Sci; 2021 Jan; 264():118718. PubMed ID: 33160997
[TBL] [Abstract][Full Text] [Related]
38. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
[TBL] [Abstract][Full Text] [Related]
39. Neohesperidin inhibits cardiac remodeling induced by Ang II in vivo and in vitro.
Zhang J; Fu X; Yang L; Wen H; Zhang L; Liu F; Lou Y; Yang Q; Ding Y
Biomed Pharmacother; 2020 Sep; 129():110364. PubMed ID: 32531678
[TBL] [Abstract][Full Text] [Related]
40. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
